Skip to content
Axe Capital logo Axe Capital Trading News

Axe Capital Investments

Clear market notes built around the JSE, the rand, and what matters locally.

Axe Capital Trading News shares simple market takes on the stories moving South African shares, the rand, and a handful of major currency pairs.

What you will find here:

1. JSE shares, South African companies, and the local knock-on effects of big market news.

2. The rand, interest rates, and a small group of forex pairs, with USD/ZAR at the centre.

3. Global stories only when they can actually change how a local investor might act.

Latest market stories

3 Space Stocks That Could Turn $10,000 Into $50,000 By 2035
2026-08-11 20:30 The Motley Fool Positive Axe Cap view: Selective

The space logistics market is projected to grow at 19% CAGR through 2034. Three space stocks—SpaceX, Rocket Lab, and AST SpaceMobile—are highlighted as potential multibaggers that could turn $10,000 into $50,000 over the next decade, though all are considered speculative investments with significant growth potential as the industry expands.

Axe note: Three US-listed space stocks promise big gains, but South Africans should tread carefully given valuations and local market context.

AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
2026-08-11 20:27 The Motley Fool Positive Axe Cap view: Selective

The article compares AbbVie and CVS Health as healthcare investment options in 2026. AbbVie, a biopharmaceutical company with a $438B market cap, is recommended as the better choice due to its focused growth trajectory, strong drug pipeline (Skyrizi and Rinvoq), and attractive dividend yield. CVS Health, a diversified healthcare provider with a $122B market cap managing 37 million medical members, is acknowledged as a turnaround story showing stabilization but is considered less compelling than AbbVie's growth prospects.

Axe note: AbbVie’s focused drug growth outshines CVS’s turnaround but consider rand risks.

Prediction: Palantir Will Hit $220 This Year. There's 1 Clear Reason Why.
2026-08-11 20:24 The Motley Fool Positive Axe Cap view: Selective

Palantir Technologies stock surged over 35% following a strong Q2 earnings report, with shares recovering year-to-date losses. The analyst predicts the stock will reach $220 before year-end, driven by the company's effective AI software solutions for commercial customers. Revenue grew 93% in Q2, with U.S. commercial revenue jumping 149%, and a Citi analyst raised the price target to $245, citing strengthening fundamentals.

Axe note: Palantir’s strong Q2 results and AI-driven growth make a compelling case for further upside.

What we follow

We keep the focus on JSE shares, the rand, and the currency moves that matter most to South African investors.

JSE and rand